These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

97 related items for PubMed ID: 3896215

  • 41. Pancreatic alpha cell autoantibodies and glucagon response to arginine.
    Winter WE, Maclaren NK, Riley WJ, Unger RH, Neufeld M, Ozand PT.
    Diabetes; 1984 May; 33(5):435-7. PubMed ID: 6373451
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Short-term effects of continuous subcutaneous insulin infusion treatment on insulin secretion in non-insulin-dependent overweight patients with poor glycaemic control despite maximal oral anti-diabetic treatment.
    Valensi P, Moura I, Le Magoarou M, Pariès J, Perret G, Attali JR.
    Diabetes Metab; 1997 Feb; 23(1):51-7. PubMed ID: 9059766
    [Abstract] [Full Text] [Related]

  • 44. Clinical and pathogenic significance of pancreatic-islet-cell antibodies in diabetics treated with oral hypoglycaemic agents.
    Irvine WJ, McCallum CJ, Gray RS, Duncan LJ.
    Lancet; 1977 May 14; 1(8020):1025-7. PubMed ID: 67485
    [Abstract] [Full Text] [Related]

  • 45. Long-term liraglutide treatment is associated with increased insulin content and secretion in β-cells, and a loss of α-cells in ZDF rats.
    Schwasinger-Schmidt T, Robbins DC, Williams SJ, Novikova L, Stehno-Bittel L.
    Pharmacol Res; 2013 Oct 14; 76():58-66. PubMed ID: 23891763
    [Abstract] [Full Text] [Related]

  • 46. Relationships between diabetes duration, metabolic control and beta-cell function in a representative population of type 2 diabetic patients in Sweden.
    Clauson P, Linnarsson R, Gottsäter A, Sundkvist G, Grill V.
    Diabet Med; 1994 Oct 14; 11(8):794-801. PubMed ID: 7851075
    [Abstract] [Full Text] [Related]

  • 47. Secretion and hepatic extraction of insulin after weight loss in obese noninsulin-dependent diabetes mellitus.
    Henry RR, Brechtel G, Griver K.
    J Clin Endocrinol Metab; 1988 May 14; 66(5):979-86. PubMed ID: 3283164
    [Abstract] [Full Text] [Related]

  • 48. T-cell responses to islet antigens improves detection of autoimmune diabetes and identifies patients with more severe beta-cell lesions in phenotypic type 2 diabetes.
    Goel A, Chiu H, Felton J, Palmer JP, Brooks-Worrell B.
    Diabetes; 2007 Aug 14; 56(8):2110-5. PubMed ID: 17473222
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Insulin and glucagon secretion in diabetic and non-diabetic patients with circulating islet cell antibodies.
    Tiengo A, Del Prete GF, Nosadini R, Betterle C, Garotti C, Bersani G.
    Diabetologia; 1977 Sep 14; 13(5):451-8. PubMed ID: 332569
    [Abstract] [Full Text] [Related]

  • 55. C-peptide and insulin secretion in diabetes mellitus treated with oral hypoglycaemic agents or diet alone. A 3 years epidemiological cohort study on the Island of Falster, Denmark.
    Nielsen NV, Tronier B.
    Diabetes Res; 1987 Mar 14; 4(3):135-9. PubMed ID: 3301161
    [Abstract] [Full Text] [Related]

  • 56. Impaired beta-cell function, incretin effect, and glucagon suppression in patients with type 1 diabetes who have normal fasting glucose.
    Greenbaum CJ, Prigeon RL, D'Alessio DA.
    Diabetes; 2002 Apr 14; 51(4):951-7. PubMed ID: 11916912
    [Abstract] [Full Text] [Related]

  • 57. Role of hyperglucagonemia in maintenance of increased rates of hepatic glucose output in type II diabetics.
    Baron AD, Schaeffer L, Shragg P, Kolterman OG.
    Diabetes; 1987 Mar 14; 36(3):274-83. PubMed ID: 2879757
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Effects of insulin therapy on non-insulin-dependent diabetics with secondary oral hypoglycemic agent failure.
    Peng YS, Juang JH.
    Changgeng Yi Xue Za Zhi; 1998 Sep 14; 21(3):271-6. PubMed ID: 9849007
    [Abstract] [Full Text] [Related]

  • 60. Effect of oral antidiabetic agents on plasma amylin level in patients with non-insulin-dependent diabetes mellitus (type 2).
    Zapecka-Dubno B, Czyzyk A, Dworak A, Bak MI.
    Arzneimittelforschung; 1999 Apr 14; 49(4):330-4. PubMed ID: 10337452
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.